Polyendocrine Metabolic Ovarian Syndrome (PMOS) is the new name for what was once called Polycystic Ovary Syndrome (PCOS). This change reflects a deeper understanding of the condition, which affects over 170 million women around the globe, or approximately 1 in 8.
The name change was led by Professor Helena Teede from Monash University. After years of research and witnessing the struggles of patients, she emphasized that the previous name misrepresented the condition. “There’s actually no increase in abnormal cysts on the ovaries,” she said. Instead, PMOS involves complex hormonal imbalances that can affect weight, mental health, skin, and reproduction.
Over 50 organizations, including the Endocrine Society, collaborated for this name change, which took 14 years to finalize. The goal was to erase misconceptions and improve care. A recent survey showed that many women felt overlooked when diagnosed, often leading to delayed treatment. This change marks a significant shift, as awareness is critical for better healthcare.
Professor Teede noted that the proper name helps reinforce the scientific accuracy of the condition. “This is a landmark moment,” she said, highlighting its potential for improving clinical practices and research.
Additionally, Lorna Berry, a woman with PMOS, shared how vital this change is for future generations. “It’s about accountability and progress,” she stated, emphasizing the need for clearer understanding from the start. Similarly, Rachel Morman, from Verity (PCOS UK), mentioned that the old name obscured the true essence of the disorder. The new name focuses on hormonal changes, pushing it into the conversation as a serious health issue.
Cultural sensitivity was also essential during the renaming process. It’s important that the terminology used does not carry stigmas that could negatively impact women in different regions.
In summary, PMOS is more than just a name change; it’s a vital step toward better understanding and treatment. As healthcare continues to evolve, recognizing the complexities of conditions like PMOS can lead to improved outcomes for millions of women worldwide.
For additional resources and information about PMOS, you can visit the Monash Centre for Health Research and Implementation.
